Figure legends
Figure 1. Comparison of COHb levels at admission and on day 5
of treatment in COVID-19 patients who did and did not develop macrophage
activation syndrome (MAS) and acute respiratory distress syndrome (ARDS)
Figure 2. Correlation analysis of COHb level with CRP and
PaO2/FiO2 levels in COVID-19 patients